The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's current earnings are $34.12 Billion USD. In 2024 the company made an earning of $4.60 Billion USD a decrease over its 2023 earnings that were of $7.85 Billion USD. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2025 (TTM) | $6.65 B | 44.28% |
2024 | $4.60 B | -41.32% |
2023 | $7.85 B | 6.93% |
2022 | $7.34 B | 9.63% |
2021 | $6.70 B | -17.61% |
2020 | $8.13 B | -11% |
2019 | $9.13 B | -4.26% |
2018 | $9.54 B | -0.54% |
2017 | $9.59 B | 4.74% |
2016 | $9.16 B | 14.85% |
2015 | $7.97 B | 42.85% |
2014 | $5.58 B | 6.08% |
2013 | $5.26 B | 5.11% |
2012 | $5.00 B | 20.7% |
2011 | $4.15 B | -21.95% |
2010 | $5.31 B | 2.17% |
2009 | $5.20 B | -0.88% |
2008 | $5.25 B | 32.54% |
2007 | $3.96 B | -1.47% |
2006 | $4.02 B | -17.42% |
2005 | $4.86 B | 43.39% |
2004 | $3.39 B | 7% |
2003 | $3.17 B | -550.38% |
2002 | -$0.71 Billion | -141.78% |
2001 | $1.68 B | 0.72% |
2000 | $1.67 B | 6.9% |
1999 | $1.56 B | 27.92% |
1998 | $1.22 B | 42.14% |
1997 | $0.86 B | -10.49% |
1996 | $0.96 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $10.34 B | 55.50% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $6.10 B | -8.15% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $5.40 B | -18.69% | ๐ฌ๐ง UK |
![]() Gilead Sciences GILD | $6.82 B | 2.63% | ๐บ๐ธ USA |
![]() Biogen BIIB | $1.75 B | -73.65% | ๐บ๐ธ USA |
![]() AbbVie ABBV | $3.62 B | -45.53% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | $27.40 B | 312.15% | ๐บ๐ธ USA |
![]() Illumina ILMN | -$0.79 Billion | -111.74% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $13.60 B | 104.52% | ๐บ๐ธ USA |